Changing of IKZF1 genotype during Philadelphia-negative precursor-B acute lymphoblastic leukemia progression: a short clinical report

Changing of IKZF1 genotype during Philadelphia-negative precursor-B acute lymphoblastic leukemia progression: a short clinical report

Bibliographic Details
Main Authors:	Volha Vshyukova, Alexander Meleshko, Natalia Mihal, Olga Aleinikova
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	Leukemia Research Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048916300048

Similar Items

IKZF1 DELETIONS ARE INDEPENDENT PROGNOSTIC FACTOR IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: G. A. Tsaur, et al.
Published: (2017-01-01)

IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform
by: Daisuke Harama, et al.
Published: (2021-06-01)

Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
by: Hong Hoe Koo
Published: (2011-03-01)

IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia
by: Bruno A. Lopes, et al.
Published: (2019-05-01)

Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
by: Sandrine Niyongere, et al.
Published: (2020-06-01)

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
by: Enrico Maffini, et al.
Published: (2019-05-01)

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
by: Davis T, et al.
Published: (2013-09-01)

High CRLF2 Expression Could Identify Acute Lymphoblastic Leukemia Patients with Poor Outcome but Not IKZF1
by: Layla M. Saleh, et al.
Published: (2021-06-01)

Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia.
by: Hailong Zhang, et al.
Published: (2014-01-01)

Detection of Pathogenic Isoforms of <em>IKZF1</em> in Leukemic Cell Lines and Acute Lymphoblastic Leukemia Samples: Identification of a Novel Truncated IKZF1 Transcript in SUP-B15
by: Weiqiang Zhao, et al.
Published: (2020-10-01)

ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.
by: Jérémie Rudant, et al.
Published: (2015-01-01)

Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
by: Tiffany-Jane Evans, et al.
Published: (2014-01-01)

Cyclin dependant kinase inhibitor 2A/B and IKZF-1 gene deletions in childhood acute lymphoblastic leukemia
by: M. Agarwal, et al.
Published: (2016-01-01)

RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia
by: Shawana Kamran, et al.
Published: (2015-01-01)

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia
by: Parveen Shiraz, et al.
Published: (2020-03-01)

Relapse after Prolonged Remission in Philadelphia-Like Acute Lymphoblastic Leukemia
by: Gaurav Shah, et al.
Published: (2019-01-01)

Imatinib Treatment Alone in Philadelphia-Positive Acute Lymphoblastic Leukemia: Is It Enough
by: Yilmaz Ay, et al.
Published: (2011-06-01)

Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia
by: Ilaria Iacobucci, et al.
Published: (2021-05-01)

PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
by: Orietta Spinelli, et al.
Published: (2014-08-01)

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01)

Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
by: Kazuki Tanimura, et al.
Published: (2021-02-01)

Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
by: Craig T Wallington-Beddoe, et al.
Published: (2012-01-01)

A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
by: Lan-Zhu Li, et al.
Published: (2020-08-01)

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia
by: Craig T. Wallington-Beddoe, et al.
Published: (2012-01-01)

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia.
by: Craig T. Wallington-Beddoe, et al.
Published: (2012-01-01)

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Satoshi Nishiwaki, et al.
Published: (2021-02-01)

Multiple Keratoacanthomas, Philadelphia Chromosome+ Acute Lymphoblastic Leukemia, and Dasatinib: A Case Report
by: Siddhant Thukral, et al.
Published: (2015-11-01)

Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
by: Yadvinder Singh, et al.
Published: (2013-11-01)

Current Concepts in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
by: Kathrin M. Bernt, et al.
Published: (2014-03-01)

IKZF1 genetic variants rs4132601 and rs11978267 and acute lymphoblastic leukemia risk in Tunisian children: a case-control study
by: Sana Mahjoub, et al.
Published: (2019-10-01)

CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways
by: Dafné Moreno Lorenzana, et al.
Published: (2021-07-01)

The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
by: Xiang Zhang, et al.
Published: (2020-10-01)

A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
by: Josep‐Maria Ribera, et al.
Published: (2020-04-01)

Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia in first salvage
by: Jae‐Ho Yoon, et al.
Published: (2019-12-01)

Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
by: Mingming Zhang, et al.
Published: (2016-01-01)

Oncogene mobility studies in Philadelphia-negative chronic myeloid leukemia and other leukemias
by: Stopera, Shelley Adenne Therese.
Published: (2012)

Oncogene mobility studies in Philadelphia-negative chronic myeloid leukemia and other leukemias
by: Stopera, Shelley Adenne Therese.
Published: (2012)

Several different cytogenetic clones arising during treatment of Philadelphia positive chronic myeloid leukemia with tyrosine kinase inhibitors lead to the progression into Philadelphia negative acute myeloid leukemia
by: Denčić-Fekete Marija, et al.
Published: (2021-01-01)

Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan
by: Yin-Chen Hsu, et al.
Published: (2021-03-01)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
by: Anagnostou T, et al.
Published: (2017-12-01)